Sun Pharm Drug Patent Portfolio

Sun Pharm's Family Patents


Family Patents





Clinical Trials

Recent Clinical Trials by Sun Pharm:

Title Lead Sponsor Collaborators Status Phases
Clinical Trials
A Study Comparing Ivermectin Cream 1%, Soolantra™ Cream 1%, PrROSIVER® Cream1% to Placebo Control in the Treatment of Moderate to Severe Facial Rosacea. Sun Pharmaceutical Industries, Inc. NA COMPLETED
(Aug 1, 2026)
PHASE1
Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer. Sun Pharmaceutical Industries Limited NA RECRUITING
(Jun 1, 2026)
PHASE2
A Study Comparing Tapinarof Cream 1% and Vtama® Cream 1% in the Treatment of Plaque Psoriasis. Sun Pharmaceutical Industries, Inc. NA COMPLETED
(Apr 1, 2026)
PHASE1
A Study Comparing Tretinoin Gel Microsphere, 0.04% and RETIN-A MICRO ® Gel Microsphere, 0.04% in the Treatment of Acne Vulgaris Sun Pharmaceutical Industries, Inc. NA COMPLETED
(Mar 1, 2026)
PHASE1


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Sun Pharm News

Projection for the Generic Oncology Medications Market by 2031 - Developments and Trends

14 Apr, 2026

Forecast for the Generic Oncology Drug Market by 2031: Trends and Growth Insights - openPR.com

14 Apr, 2026

AstraZeneca and Sun Resolve Patent Disputes Concerning Three Diabetes Medications - Bloomberg Law News

09 Apr, 2026

Novo Nordisk Focuses on Local Partnerships and Price Reductions Amidst Increasing Competition from Generic Weight-Loss Medications

05 Apr, 2026

See More